PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced the appointment of Michelle Carpenter, JD, RAC, to the position of vice president of regulatory affairs and quality. Ms. Carpenter will lead and manage the company’s regulatory and quality personnel and activities including key negotiations with the FDA regarding clinical development initiatives. Her experience further strengthens Oculus’ management team in preparation for the upcoming End-of-Phase II meeting discussions with the FDA.
